维普中文期刊产品整合服务
17篇 您的检索式:作者名="Minoru Tanabe"
    题名 作者 年代 出处 被引量
1Enhanced recovery program is safe and improves postoperative insulin resistance in gastrectomy显示文摘AIM: To assess the safety of enhanced recovery after surgery(ERAS) program in gastrectomy and influences on nutrition state and insulin-resistance. METHODS: Our ERAS program involved shortening the fasting periods and preoperative carbohydrate loading. Eighty gastrectomy patients were randomly assigned to either the conventional group(CG) or ERAS group(EG). We assessed the clinical characteristics and postoperative outcomes prospectively. The primary endpoint was noninferiority in timely discharge from the hospital within 12 d. Secondary endpoints were the incidence of aspiration at anesthesia induction, incidence of postoperative complications, health related quality of life(HRQOL) using the SF8 Health Survey questionnaire, nutrition state [e.g., albumin, transthyretin(TTR), retinal-binding protein(RBP), and transferrin(Tf)], the homeostasis model assessment-insulin resistance(HOMA-R) index, postoperative urine volume,postoperative weight change, and postoperative oral intake.RESULTS: The ERAS program was noninferior to the conventional program in achieving discharge from the hospital within 12 d(95.0% vs 92.5% respectively; 95%CI:-10.0%-16.0%). There was no significant difference in postoperative morbidity between the two groups. Adverse events such as vomiting and aspiration associated with the induction of general anesthesia were not observed. There were no significant differences with respect to postoperative urine volume, weight change, and oral intake between the two groups. EG patients with preoperative HOMA-R scores above 2.5 experienced significant attenuation of their HOMA-R scores on postoperative day 1 compared to CG patients(P = 0.014). There were no significant differences with respect to rapid turnover proteins(TTR, RBP and Tf) or HRQOL scores using the SF8 method.CONCLUSION: Applying the ERAS program to patients who undergo gastrectomy is safe, and improves insulin resistance with no deterioration in QOL.Nobuaki Fujikuni Kazuaki Tanabe Noriaki Tokumoto Takahisa Suzuki Minoru Hattori Toshihiro Misumi Hideki Ohdan 2016World Journal of Gastrointestinal Surgery2016,8,5:23
2Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy显示文摘Hiroto Izumi Takayuki Torigoe Hiroshi Ishiguchi Hidetaka Uramoto Yoichiro Yoshida Mizuho Tanabe Tomoko Ise Tadashi Murakami Takeshi Yoshida Minoru Nomoto Kimitoshi Kohno 2003Cancer Treatment Reviews2003,,6:2
3The influence of donor age on liver regeneration and hepatic progenitor cell populations显示文摘Yoshihiro Ono Shigeyuki Kawachi Tetsu Hayashida Masatoshi Wakui Minoru Tanabe Osamu Itano Hideaki Obara Masahiro Shinoda Taizo Hibi Go Oshima Noriyuki Tani Kisyo Mihara Yuko Kitagawa 2011Surgery2011,,2:2
4Liver atrophy after percutaneous transhepatic portal embolization occurs in two histological phases: Hepatocellular atrophy followed by apoptosis显示文摘AIM To clarify the histological changes associated with liver atrophy after percutaneous transhepatic portalembolization(PTPE) in pigs and humans. METHODS As a preliminary study, we performed pathological examinations of liver specimens from five pigs that had undergone PTPE in a time-dependent model of liver atrophy. In specimens from embolized lobes(EMB) and nonembolized lobes(controls), we measured the portal vein to central vein distance(PV-CV), the area and number of hepatocytes per lobule, and apoptotic activity using the terminal deoxynucleotidyl transferase dU TP nickend labeling assay. Immunohistochemical reactivities were evaluated for light chain 3(LC3) and lysosomal-associated membrane protein 2(LAMP2) as autophagy markers and for glutamine synthetase and cytochrome P450 2 E1(CYP2 E1) as metabolic zonation markers. Samples from ten human livers taken 20-36 d after PTPE were similarly examined. RESULTS PV-CVs and lobule areas did not differ between EMB and controls at day 0, but were lower in EMB than in controls at weeks 2, 4, and 6(P ≤ 0.001). Hepatocyte numbers were not significantly reduced in EMB at day 0 and week 2 but were reduced at weeks 4 and 6(P ≤ 0.05). Apoptotic activity was higher in EMB than in controls at day 0 and week 4. LC3 and LAMP2 staining peaked in EMB at week 2, with no significant difference between EMB and controls at weeks 4 and 6. Glutamine synthetase and CYP2 E1 zonation in EMB at weeks 2, 4, and 6 were narrower than those in controls. Human results were consistent with those of porcine specimens. CONCLUSION The mechanism of liver atrophy after PTPE has two histological phases: Hepatocellular atrophy is likely caused by autophagy in the first 2 wk and apoptosis thereafter.Yasuhito Iwao Hidenori Ojima Tatsushi Kobayashi Yoji Kishi Satoshi Nara Minoru Esaki Kazuaki Shimada Nobuyoshi Hiraoka Minoru Tanabe Yae Kanai 2017World Journal of Hepatology2017,9,32:1
5Gallbladder carcinoma with osteoclast-like giant cells显示文摘Tomotaka Akatsu Kaori Kameyama Shigeyuki Kawachi Minoru Tanabe Koichi Aiura Go Wakabayashi Masakazu Ueda Motohide Shimazu Masaki Kitajima 2006Journal of Gastroenterology2006,,1:1
6Suppressive Effects of Interleukin-18 on Liver Function in Rat Liver Allografts显示文摘Shigeshi Ono Hideaki Obara Atsushi Takayanagi Minoru Tanabe Shigeyuki Kawachi Osamu Itano Masahiro Shinoda Minoru Kitago Taizo Hibi Tomohiro Chiba Wenlin Du Kenji Matsumoto Arno W. Tilles Martin L. Yarmush Sadakazu Aiso Nobuyoshi Shimizu Michiie Sakamoto 2012Journal of Surgical Research2012,,1:1
7Clinicopathological characteristics and prognostic impact of colorectalcancers with NRAS mutations显示文摘Toshiro Ogura Miho Kakuta Toshimasa Yatsuoka Yoji Nishimura Hirohiko Sakamoto Kensei Yamaguchi Minoru Tanabe Yoichi Tanaka Kiwamu Akagi 2014Oncology Reports2014,,1:1
8Advances in reduced port laparoscopic liver resection显示文摘Daisuke Ban Atsushi Kudo Takumi Irie Takanori Ochiai Arihiro Aihara Satoshi Matsumura Shinji Tanaka Minoru Tanabe 2015Asian J Endosc Surg2015,,1:1
9Consequences of Living-Donor Liver Transplantation for Upper Gastrointestinal Lesions: High Incidence of Reflux Esophagitis显示文摘Tomotaka Akatsu Masashi Yoshida Shigeyuki Kawachi Minoru Tanabe Motohide Shimazu Koichiro Kumai Masaki Kitajima 2006Digestive Diseases and Sciences2006,,11:1
10Protective Effect of High-Mobility Group Box 1 Blockade on Acute Liver Failure in Rats显示文摘Kiminori Takano Masahiro Shinoda Minoru Tanabe Taku Miyasho Shingo Yamada Shigeshi Ono Yohei Masugi Koichi Suda Koichi Fukunaga Tetsu Hayashida Taizo Hibi Hideaki Obara Hiroya Takeuchi Shigeyuki Kawachi Kazufumi Kawasako Minoru Okamoto Hiroshi Yokota Ikur 2010Shock2010,,6:1
11Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging显示文摘Minoru Hayashida Katsuyoshi Ito Takeshi Fujita Ayame Shimizu Katsumi Sasaki Masahiro Tanabe Naofumi Matsunaga 2008Magnetic Resonance Imaging2008,,1:1
12A novel difficulty scoring system for laparoscopic liver resection显示文摘Daisuke Ban Minoru Tanabe Hiromitsu Ito Yuichiro Otsuka Hiroyuki Nitta Yuta Abe Yasushi Hasegawa Toshio Katagiri Chisato Takagi Osamu Itano Hironori Kaneko Go Wakabayashi 2014J Hepatobiliary Pancreat Sci2014,,10:1
13Transvaginal hybrid natural orifice translumenal endoscopic surgery appendectomy显示文摘Norihito Wada Minoru Tanabe Fumio 2013Nihon Geka Gakkai zasshi2013,114,6:1
14Biliary complications in adult living donor liver transplantation with duct-to-duct hepaticocholedochostomy or Roux-en-Y hepaticojejunostomy biliary reconstruction显示文摘Shigeyuki Kawachi Motohide Shimazu Go Wakabayashi Ken Hoshino Minoru Tanabe Masashi Yoshida Yasuhide Morikawa Masaki Kitajima 2002Surgery2002,,1:1
15Squamous cell carcinoma of the liver originating from non-parasitic cysts after a 15 year follow-up显示文摘Hiroshi Yagi Masakazu Ueda Shigeyuki Kawachi Minoru Tanabe Kouichi Aiura Go Wakabayashi Motohide Shimazu Mituie Sakamoto Masaki Kitajima 2004European Journal of Gastroenterology & Hepatology2004,,10:1
16Pseudoaneurysm of the Cystic Artery Secondary to Cholecystitis as a Cause of Hemobilia: Report of a Case显示文摘Tomotaka Akatsu Minoru Tanabe Tomohiro Shimizu Kan Handa Shigeyuki Kawachi Koichi Aiura Masakazu Ueda Motohide Shimazu Masaki Kitajima 2007Surgery Today2007,,5:1
17Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation1显示文摘Minoru Tanabe Motohide Shimazu Go Wakabayashi Ken Hoshino Shigeyuki Kawachi Tomohisa Kadomura Hiroaki Seki Yasuhide Morikawa Masaki Kitajima 2002Transplantation2002,,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费